Dr. David A. Lester

D.D.S. | Dentist



  
  2834 Crescent Ave, Eugene
  Oregon, 97408-7397

  541-686-9372    541-485-6706 Maps & Directions
Dr. David A. Lester is a Eugene, Oregon based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 2834 Crescent Ave, Eugene. Patients can reach him at 541-686-9372.
Dr. David A. Lester is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. David A. Lester speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. David A. Lester
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:2834 Crescent Ave, Eugene,
Oregon, 97408-7397
Phone:541-686-9372
Fax:541-485-6706
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 6901867241
Enrollment ID: I20160602001481
NPI Number: 1154314599
NPI Enumeration Date: 30 Aug, 2005
NPI Last Update On: 16 Feb, 2012

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 2834 Crescent Ave,
Eugene, Oregon
Zip: 97408-7397
Phone Number: 541-686-9372
Fax Number: 541-485-6706
Patients can reach Dr. David A. Lester at 2834 Crescent Ave, Eugene, Oregon or can call to book an appointment on 541-686-9372. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: